Glow
BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg
The full picture
What Glow is — in plain English.
An educational overview: what it is, what people use it for, how it works, and who it is not for. This is not a grade or a claim of effectiveness.
What's in it
| PEPTIDE | DOSE | ROLE IN THIS BLEND |
|---|---|---|
| GHK-Cu | 50mg | The renewal signal. A copper-binding peptide that supports collagen and elastin production, skin remodeling, and connective-tissue repair. |
| BPC-157 | 10mg | The protector. Contributes general tissue repair and anti-inflammatory support underneath the skin-focused effect. |
| TB-500 | 10mg | The circulation piece. Promotes cell migration and new blood vessel formation, supporting circulation to the skin and connective tissue. |
The combination logic
GHK-Cu is the ingredient doing the skin-specific work — it’s tied to collagen and elastin production. BPC-157 and TB-500 are added underneath that to support general tissue repair and circulation, since skin health depends on the connective tissue and blood supply beneath it, not just the surface layer. Clinical detail: GHK-Cu delivers bioavailable copper and drives collagen, elastin, and glycosaminoglycan synthesis; at the genetic level it has been shown to influence expression of hundreds of repair-related genes and raise antioxidant enzyme activity. BPC-157 contributes broad cytoprotective and angiogenic support via VEGFR2-Akt-eNOS pathway modulation. TB-500 promotes cell motility and angiogenesis via actin regulation and VEGF upregulation. The combination is proposed to support skin renewal (GHK-Cu) on top of the circulatory and connective-tissue foundation the other two provide.
Is there evidence for the combination, or only for the parts? GHK-Cu has real human evidence for skin-related effects, largely from topical cosmetic research; injectable/systemic use has less direct human data. BPC-157 and TB-500 remain laboratory-data-primarily for their proposed mechanisms, and no direct combination trial exists for either pairing within this blend. The rationale for combining a skin-focused peptide with two general repair peptides is mechanistic layering, not comparative trial evidence.
What it's used for
| USED FOR | IN SHORT |
|---|---|
| Skin firmness, collagen support Connective-tissue and dermal repair | GHK-Cu has the most developed evidence of the three for skin-specific effects, including human topical and injectable research. BPC-157 and TB-500 contribute general repair support underneath the skin-specific GHK-Cu effect. |
| Post-procedural or post-injury skin recovery | A commonly cited use for this three-peptide combination, tying general tissue repair to skin-specific renewal. |
Overlaps & stacked risks
- GHK-Cu’s copper-delivery mechanism means copper levels should be monitored during extended systemic use.
- TB-500’s angiogenic mechanism is a theoretical concern for any undiagnosed abnormal tissue growth.
- Combining three active peptides carries the summed risk profile of all three.
- Mild injection-site irritation is the most commonly reported effect across all three components.
Who it is not for
- Pregnant or breastfeeding patients
- Patients with copper-metabolism disorders — GHK-Cu delivers bioavailable copper and should be monitored in extended use
- Anyone with a personal or family history of cancer, without physician clearance, given TB-500’s angiogenic mechanism
- Anyone on anticoagulant medication without provider review
Who it suits
Patients seeking skin firmness, collagen support, or general dermal renewal alongside underlying tissue repair, who have no copper-metabolism disorder or active malignancy concern.
Who makes this, and under what rules
Everything dispensed here is prepared by a licensed 503A compounding pharmacy — not bought from a supplier and repackaged, and not sourced from an online seller. That designation carries specific, enforceable obligations:
- A prescription in your name. Compounded from a prescription for one identified patient, after an evaluation.
- Licensed and inspected. A state license, subject to inspection by the state board of pharmacy.
- Sterile preparation to a published standard. USP standards.
- A paper trail. A lot number and beyond-use date on every preparation.
A compounded preparation is not an FDA-approved medicine — but it is the difference between a licensed pharmacy working to a standard and an unregulated website. This page describes Glow for general educational purposes. It is not medical advice and does not replace a consultation with a licensed provider. Individual results vary, and combination products carry the risks of each included peptide.
Products are available only by prescription after a consultation with a licensed provider, who decides whether treatment is appropriate. Many compounds described here are not FDA-approved medicines and have not been tested in people for the uses described; information on this site is educational and is not medical advice.